Rehabilitation for long COVID-19 symptoms
Intervention Against Long COVID in Norway - Systematic Rehabilitation. A Randomised Pilot and Feasibility Study.
This study is testing a rehabilitation program for people with long COVID-19 symptoms, especially those affecting their thinking and daily life, to see if it helps them feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University Hospital of North Norway Academic / other |
| Locations | 1 site (Tromsø, Troms) |
| Trial ID | NCT06085911 on ClinicalTrials.gov |
What this trial studies
This clinical trial focuses on developing treatment interventions for individuals suffering from long COVID-19, particularly those experiencing neurocognitive symptoms that impact daily activities. Participants will undergo a one-day course followed by individual follow-ups to assess the effectiveness of the rehabilitation approach. The study aims to quantify the prevalence and underlying mechanisms of long COVID while addressing the significant burden it places on healthcare services. The trial is conducted in collaboration with several prominent Norwegian universities and hospitals.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 65 who exhibit symptoms of long COVID affecting their daily activities and have a positive COVID-19 test.
Not a fit: Patients with pre-existing chronic neurocognitive diseases or those unwilling to comply with study protocols may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide effective rehabilitation strategies for patients suffering from long COVID, improving their quality of life and daily functioning.
How similar studies have performed: While there is ongoing research into long COVID rehabilitation, this specific approach is novel and aims to fill gaps in current knowledge and treatment strategies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Symptoms attributable to long COVID according to WHO definition \[14\] that affect their daily activities * Positive Covid test; a home-test, PCR test or serology. * Neurocognitive symptoms * Age between 18 and 65 years * Participant is able and willing to provide informed consent Exclusion Criteria: * Patients that do not want to comply to planned physical study visits * Patients who are unable to complete surveys in Norwegian * Patients with known chronic neurocognitive disease before Covid-19 or other diseases that can explain current symptoms
Where this trial is running
Tromsø, Troms
- University hospital of North Norway — Tromsø, Troms, Norway (Recruiting)
Study contacts
- Principal investigator: Maja Wilhelmsen, ph.d — University Hospital of North Norway
- Study coordinator: Maja Wilhelmsen, MD, Ph.d
- Email: maja.wilhelmsen@unn.no
- Phone: +4777627834
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.